Holding(s) in Company
Rathbones Investment Management Ltd, ultimately controlled by Rathbones Group Plc, now holds 9,679,837 ordinary shares in Fusion Antibodies plc, representing approximately 7.74 per cent. of the Company's issued share capital. These shares are registered in the name of Rathbones Nominees Limited.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, was informed today that Rathbones Investment Management Ltd (ultimately controlled by Rathbones Group Plc) now holds 9,679,837 ordinary shares of 4 pence each in the Company, representing approximately 7.74 per cent. of the Company's issued share capital. These shares are registered in the name of Rathbones Nominees Limited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.